Code |
Title |
–
|
Top Categories
|
3 |
Administration
|
3E |
Physiological Systems and Anatomical Regions
|
3E0
|
Introduction
Administration, Physiological Systems and Anatomical Regions, Introduction
|
3E0Q |
Cranial Cavity and Brain
|
3E0Q0 |
Open
|
3E0Q00 |
Antineoplastic
|
3E0Q004
|
Liquid Brachytherapy Radioisotope
Introduction of Liquid Brachytherapy Radioisotope into Cranial Cavity and Brain, Open Approach
|
3E0Q005
|
Other Antineoplastic
Introduction of Other Antineoplastic into Cranial Cavity and Brain, Open Approach
|
3E0Q00M
|
Monoclonal Antibody
Introduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Open Approach
|
3E0Q02 |
Anti-infective
|
3E0Q028
|
Oxazolidinones
Introduction of Oxazolidinones into Cranial Cavity and Brain, Open Approach
|
3E0Q029
|
Other Anti-infective
Introduction of Other Anti-infective into Cranial Cavity and Brain, Open Approach
|
3E0Q03 |
Anti-inflammatory
|
3E0Q03Z
|
No Qualifier
Introduction of Anti-inflammatory into Cranial Cavity and Brain, Open Approach
|
3E0Q06 |
Nutritional Substance
|
3E0Q06Z
|
No Qualifier
Introduction of Nutritional Substance into Cranial Cavity and Brain, Open Approach
|
3E0Q07 |
Electrolytic and Water Balance Substance
|
3E0Q07Z
|
No Qualifier
Introduction of Electrolytic and Water Balance Substance into Cranial Cavity and Brain, Open Approach
|
3E0Q0A |
Stem Cells, Embryonic
|
3E0Q0AZ
|
No Qualifier
Introduction of Embryonic Stem Cells into Cranial Cavity and Brain, Open Approach
|
3E0Q0B |
Anesthetic Agent
|
3E0Q0BZ
|
No Qualifier
Introduction of Anesthetic Agent into Cranial Cavity and Brain, Open Approach
|
3E0Q0E |
Stem Cells, Somatic
|
3E0Q0E0
|
Autologous
Introduction of Autologous Somatic Stem Cells into Cranial Cavity and Brain, Open Approach
|
3E0Q0E1
|
Nonautologous
Introduction of Nonautologous Somatic Stem Cells into Cranial Cavity and Brain, Open Approach
|
3E0Q0G |
Other Therapeutic Substance
|
3E0Q0GC
|
Other Substance
Introduction of Other Therapeutic Substance into Cranial Cavity and Brain, Open Approach
|
3E0Q0H |
Radioactive Substance
|
3E0Q0HZ
|
No Qualifier
Introduction of Radioactive Substance into Cranial Cavity and Brain, Open Approach
|
3E0Q0K |
Other Diagnostic Substance
|
3E0Q0KZ
|
No Qualifier
Introduction of Other Diagnostic Substance into Cranial Cavity and Brain, Open Approach
|
3E0Q0N |
Analgesics, Hypnotics, Sedatives
|
3E0Q0NZ
|
No Qualifier
Introduction of Analgesics, Hypnotics, Sedatives into Cranial Cavity and Brain, Open Approach
|
3E0Q0S |
Gas
|
3E0Q0SF
|
Other Gas
Introduction of Other Gas into Cranial Cavity and Brain, Open Approach
|
3E0Q0T |
Destructive Agent
|
3E0Q0TZ
|
No Qualifier
Introduction of Destructive Agent into Cranial Cavity and Brain, Open Approach
|
3E0Q3 |
Percutaneous
|
3E0Q30 |
Antineoplastic
|
3E0Q304
|
Liquid Brachytherapy Radioisotope
Introduction of Liquid Brachytherapy Radioisotope into Cranial Cavity and Brain, Percutaneous Approach
|
3E0Q305
|
Other Antineoplastic
Introduction of Other Antineoplastic into Cranial Cavity and Brain, Percutaneous Approach
|
3E0Q30M
|
Monoclonal Antibody
Introduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Percutaneous Approach
|
3E0Q32 |
Anti-infective
|
3E0Q328
|
Oxazolidinones
Introduction of Oxazolidinones into Cranial Cavity and Brain, Percutaneous Approach
|
3E0Q329
|
Other Anti-infective
Introduction of Other Anti-infective into Cranial Cavity and Brain, Percutaneous Approach
|
3E0Q33 |
Anti-inflammatory
|
3E0Q33Z
|
No Qualifier
Introduction of Anti-inflammatory into Cranial Cavity and Brain, Percutaneous Approach
|
3E0Q36 |
Nutritional Substance
|
3E0Q36Z
|
No Qualifier
Introduction of Nutritional Substance into Cranial Cavity and Brain, Percutaneous Approach
|
3E0Q37 |
Electrolytic and Water Balance Substance
|
3E0Q37Z
|
No Qualifier
Introduction of Electrolytic and Water Balance Substance into Cranial Cavity and Brain, Percutaneous Approach
|
3E0Q3A |
Stem Cells, Embryonic
|
3E0Q3AZ
|
No Qualifier
Introduction of Embryonic Stem Cells into Cranial Cavity and Brain, Percutaneous Approach
|
3E0Q3B |
Anesthetic Agent
|
3E0Q3BZ
|
No Qualifier
Introduction of Anesthetic Agent into Cranial Cavity and Brain, Percutaneous Approach
|
3E0Q3E |
Stem Cells, Somatic
|
3E0Q3E0
|
Autologous
Introduction of Autologous Somatic Stem Cells into Cranial Cavity and Brain, Percutaneous Approach
|
3E0Q3E1
|
Nonautologous
Introduction of Nonautologous Somatic Stem Cells into Cranial Cavity and Brain, Percutaneous Approach
|
3E0Q3G |
Other Therapeutic Substance
|
3E0Q3GC
|
Other Substance
Introduction of Other Therapeutic Substance into Cranial Cavity and Brain, Percutaneous Approach
|
3E0Q3H |
Radioactive Substance
|
3E0Q3HZ
|
No Qualifier
Introduction of Radioactive Substance into Cranial Cavity and Brain, Percutaneous Approach
|
3E0Q3K |
Other Diagnostic Substance
|
3E0Q3KZ
|
No Qualifier
Introduction of Other Diagnostic Substance into Cranial Cavity and Brain, Percutaneous Approach
|
3E0Q3N |
Analgesics, Hypnotics, Sedatives
|
3E0Q3NZ
|
No Qualifier
Introduction of Analgesics, Hypnotics, Sedatives into Cranial Cavity and Brain, Percutaneous Approach
|
3E0Q3S |
Gas
|
3E0Q3SF
|
Other Gas
Introduction of Other Gas into Cranial Cavity and Brain, Percutaneous Approach
|
3E0Q3T |
Destructive Agent
|
3E0Q3TZ
|
No Qualifier
Introduction of Destructive Agent into Cranial Cavity and Brain, Percutaneous Approach
|
3E0Q7 |
Via Natural or Artificial Opening
|
3E0Q70 |
Antineoplastic
|
3E0Q704
|
Liquid Brachytherapy Radioisotope
Introduction of Liquid Brachytherapy Radioisotope into Cranial Cavity and Brain, Via Natural or Artificial Opening
|
3E0Q705
|
Other Antineoplastic
Introduction of Other Antineoplastic into Cranial Cavity and Brain, Via Natural or Artificial Opening
|
3E0Q70M
|
Monoclonal Antibody
Introduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Via Natural or Artificial Opening
|
3E0Q7S |
Gas
|
3E0Q7SF
|
Other Gas
Introduction of Other Gas into Cranial Cavity and Brain, Via Natural or Artificial Opening
|